Table 4.
Lung Function | Soluble Fibre Group | p † | Control Group | p † | p * | ||
---|---|---|---|---|---|---|---|
0 h | ∆4 h | 0 h | ∆4 h | ||||
(n) | 17 | 17 | 12 | 12 | |||
FEV1 (L) ^ | 2.7 [2.2, 3.6] | 0.1 [0.0, 0.2] | 0.022 | 2.9 [2.0, 3.5] | 0.1 [−0.1, 0.2] | 0.347 | 0.341 |
FEV1 (% predicted) # | 82.4 ± 4.4 | 4.0 ± 1.6 | 0.024 | 77.7 ± 6.8 | 1.0 ± 1.4 | 0.506 | 0.190 |
FVC (L) ^ | 4.1 [3.4, 4.7] | 0.0 [−0.1, 0.1] | 0.331 | 4.0 [3.5, 4.9] | 0.01 [−0.04, 0.1] | 0.503 | 0.595 |
FVC (% predicted) # | 98.9 ± 3.4 § | 1.6 ± 1.2 | 0.193 | 86.9 ± 4.5 | −0.2 ± 1.0 | 0.859 | 0.285 |
FEV1/FVC (%) # | 69.2 ± 2.5 | 3.8 ± 1.1 | 0.002 | 71.9 ± 4.6 | 1.2 ± 0.7 | 0.101 | 0.070 |
FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity. ^ Data are nonparametric, presented as median [quartile 1, quartile 3], within-group changes analyzed by Wilcoxon matched pairs signed-rank test and group comparison performed using Wilcoxon rank-sum test. # Data are normally distributed and presented as means ± SEMs, within group changes analyzed by paired t-test and group comparison performed using two-sample t-test. § p < 0.05 versus control group at baseline. † Difference in change from 0 to 4 h within group. * Difference in change from 0 to 4 h between the soluble fibre and control group.